by editor | Feb 8, 2016 | Blog
NOTE: This company now trades as GeneSYS ID, Inc. (OTCQB: GNID). Rx Safes Effectuates Re-Capitalization to Meet Investment Banking Criteria Company Announces Non-Deal Roadshow in New York City HENDERSON, NV–(Marketwired – Feb 8, 2016) – Rx Safes,...
by editor | Jan 27, 2016 | Blog
NOTE: This company now trades as GeneSYS ID, Inc. (OTCQB: GNID). .. Rx Safes Announces New Patent License Agreement Company Agrees to License IP to Manufacturer and Seller of Fingerprint Products HENDERSON, NV–(Marketwired – Jan 27, 2016) – Rx...
by GlobeNewsWire | Jan 11, 2016 | Globe Newswire, GNW Alerts
ST. LOUIS, Jan. 11, 2016 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that it has initiated its first prospective, multi-center, randomized clinical study...